DCM
ZBH icon

Decatur Capital Management’s Zimmer Biomet ZBH Stock Holding History

Decatur Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-89,117
Closed -$10.6M – 82
2017
Q1 		$10.6M Buy
89,117
+50,045
+128% +$5.67M 2.06% 13
2016
Q4 		$3.92M Buy
39,072
+4,982
+15% +$534K 0.56% 50
2016
Q3 		$4.3M Sell
34,090
-11
-0% -$1.36K 0.54% 52
2016
Q2 		$3.98M Sell
34,101
-10,094
-23% -$1.14M 0.54% 52
2016
Q1 		$4.58M Hold
44,195
– – 0.6% 48
2015
Q4 		$4.4M Buy
44,195
+85
+0.2% +$8.32K 0.56% 50
2015
Q3 		$4.02M Buy
+44,110
New +$4.42M 0.55% 48

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Decatur Capital Management's ZBH Position: Q2 2017 in Review

Decatur Capital Management sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 89,117 shares — an estimated $10.6M sold.

Decatur Capital Management first reported a position in ZBH in Q3 2015 and held it in 7 quarters. The position peaked at $10.6M in Q1 2017. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Decatur Capital Management reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
  • Decatur Capital Management sold 89,117 Zimmer Biomet shares in Q2 2017, an estimated $10.6M.
  • Decatur Capital Management first reported a position in Zimmer Biomet in Q3 2015 and held it in 7 quarters.
  • Decatur Capital Management's Zimmer Biomet position peaked at $10.6M in Q1 2017.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Decatur Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.